Atea Pharmaceuticals (AVIR) Earnings Date & Reports

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AVIR is expected to report earnings to fall 1.75% to -56 cents per share on August 06

Atea Pharmaceuticals AVIR Stock Earnings Reports

Q2'26

Est.

$-0.56

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.13

Q3'25

Missed

by $0.11

Q2'25

Missed

by $0.03

The last earnings report on May 12 showed earnings per share of -56 cents, missing the estimate of -56 cents. With 99.98K shares outstanding, the current market capitalization sits at 347.72M.

View a ticker or compare two or three

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+18%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

AVIR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement